Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial electron transport chain (ETC) and associated redox systems comprise a series of protein complexes (Complex I-V) and electron carriers located in the inner mitochondrial membrane. These systems facilitate oxidative phosphorylation, converting energy from nutrients into adenosine triphosphate (ATP) while maintaining cellular redox homeostasis [1]. They play a critical role in disease; mutations or dysfunction are linked to primary mitochondrial disorders, neurodegeneration, and metabolic syndromes, while cancer cells often reprogram these pathways to support rapid proliferation [2]. Pharmacological intervention involves either inhibiting specific complexes to induce cell death in tumors or using redox-active molecules to bypass defects in genetic mitochondrial diseases [3]. For example, Metformin targets Complex I to modulate glucose metabolism, while Atovaquone targets Complex III for its antiparasitic and potential anticancer effects [4]. However, targeting the ETC is challenging due to the risk of systemic toxicity, such as lactic acidosis or impaired energy production in high-demand tissues like the heart and brain [5]. [1] StatPearls: Physiology, Mitochondrial Electron Transport Chain (https://www.ncbi.nlm.nih.gov/books/NBK526040/) [2] Nature Reviews Molecular Cell Biology: Mitochondria in health and disease (https://www.nature.com/articles/nrm3327) [3] Nature Reviews Drug Discovery: Targeting mitochondria for cancer therapy (https://www.nature.com/articles/nrd.2016.58) [4] PubMed: Metformin and the mitochondria (https://pubmed.ncbi.nlm.nih.gov/24571926/) [5] Journal of Clinical Medicine: Drug-Induced Mitochondrial Toxicity (https://www.mdpi.com/2077-0383/9/10/3134)
Inhibition of specific respiratory complexes (I-V) to disrupt ATP production or induce apoptosis, or the use of redox-active carriers to bypass metabolic blocks and reduce oxidative stress.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Electron Transport Chain and Redox Systems (ETC).